Official Title
The Neuroimage Study of the Neuromuscular Disorders.
Brief Title
The Neuroimage Study of the Neuromuscular Disorders.
Protocol ID
NCT05048862
Lead Sponsor
National Taiwan University Hospital
Brief Summary
The neuromuscular disorders could be briefly divided to neuropathy, myopathy, motor
neuron disease, and neuromuscular junction disorder. In the past, the evaluation of the
neuromuscular disorders depended on several ways (ex. electrodiagnostic studies and
biopsy) to evaluate the pathophysiology and the pathological change. However, due to the
issue of resolution, few image studies were available to evaluate the structure for
clinical practice. With the growing techniques, there are two ways to see the nerve and
muscle in vivo, the magnetic resonance imaging (MRI) and the ultrasonography. The
availability of the machine, the high cost, inability to change the position for dynamic
views of the nerves, and the relative invasion considering the large energy penetrating
the patient might limit the clinical use of MRI. The nerve ultrasonography is a safe and
easily available technique. The development of high-frequency transducers has led to an
improvement in the resolution of ultrasonography and enables the exploration of
peripheral nerve and muscle structural changes. In additional to evaluate the
morphological changes, ultrasonography has been used extensively for the vessel status
assessment through duplex ultrasound. In present study, we will apply variable
approaches, including to muscle, nerve, and skin biopsy, electrophysiological study,
quantitative sensory testing, autonomic functional tests, pain evoked potentials, MRI,
and ultrasonography to integrally investigate the different aspects of neuromuscular
disorders. The results of the study will provide integrated insights of (1) the
neurophysiology of nerve and vessels and (2) pathogenesis of different neuromuscular
disorders.
Detailed Description
This is a prospective observational study which will be performed in both the inpatient
and outpatient setting of National Taiwan University Hospital. Patients age at least 20
years, and have been diagnosed as neuromuscular disorders by the neurologist. Patients
who are unable to read the questionnaire, fail to accept all the examinations, and refuse
to provide inform consent are excluded from this study. The normal group (age at least 20
years) who had no neurological symptoms or signs were also recruited. The neurological
examination performed by the board neurologist must be normal in the normal group.
Different interventions were performed periodically to see the serial change. The
interval between the interventions is within 1 month and there is no new symptoms or any
events.
Study Period
-
Enrollment Count
500 participants
Eligibility Criteria
Inclusion Criteria (Neuromuscular group):
- been diagnosed as neuromuscular disorders by the neurologist
- at least 20-year-old
Inclusion Criteria (Normal group):
- no past history of neurological disorders.
- The neurological examination performed by the board neurologist must be normal
- at least 20-year-old
Exclusion Criteria (Neuromuscular and normal group):
- Patients who are unable to read the questionnaire, fail to accept all the
examinations, and refuse to provide inform consent
Filters
Neuromuscular Diseases
RECRUITING
ADULT
OLDER_ADULT